Ranbaxy sets out to conquer global markets
Facebook Twitter google+ RSS Feed

Ranbaxy sets out to conquer global markets

By SiliconIndia   |   Wednesday, 22 October 2003, 07:00 Hrs
Printer Print Email Email
KOLKATA: To leverage its strength in the global antibiotic markets, Indian pharmaceutical giant, Ranbaxy Laboratory Limited is now betting big on the revolutionary OD (once-a-day dosage) antibiotic formulations.

The company is planning to go global with this niche segment and has lined up a strategy for phased launch of these formulations and future growth.

The formulations that are being considered for launch by Ranbaxy in different markets across the world are its three blockbuster OD formulations in the domestic market --- ciprofloxacin OD (Cifran OD), ofloxacin OD (Zanocin OD) and clarithromycin OD (Crixan OD).

For starters, Ranbaxy has planned launch of the OD antibiotic formulations under its own brand in markets where it already has strong presence like China, Brazil, Myanmar, and Cambodia.

Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Sr. Executive
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
Reena Khanna
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset